carbamazepine has been researched along with Chronic Progressive Multiple Sclerosis in 2 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report 11 MS patients with trigeminal neuralgia (TN): 6 intolerant to a therapeutic dosage of CBZ, showing serious adverse effects and subsequently treated with a combination of low-dose CBZ and gabapentin (GBP) (group 1); 5 treated with lamotrigine (LMT), showing adverse effects and subsequently treated with GBP (group 2)." | 7.70 | Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. ( Leandri, M; Mancardi, GL; Messmer Uccelli, M; Solaro, C; Uccelli, A, 2000) |
| "Epileptic seizures associated with intrathecal baclofen (ITB) application have been observed in patients with traumatic brain injury." | 3.77 | Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine. ( Bramanti, P; D'Aleo, G; Kofler, M; Rifici, C; Saltuari, L; Sessa, E, 2011) |
| " We report 11 MS patients with trigeminal neuralgia (TN): 6 intolerant to a therapeutic dosage of CBZ, showing serious adverse effects and subsequently treated with a combination of low-dose CBZ and gabapentin (GBP) (group 1); 5 treated with lamotrigine (LMT), showing adverse effects and subsequently treated with GBP (group 2)." | 3.70 | Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. ( Leandri, M; Mancardi, GL; Messmer Uccelli, M; Solaro, C; Uccelli, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Aleo, G | 1 |
| Rifici, C | 1 |
| Kofler, M | 1 |
| Sessa, E | 1 |
| Saltuari, L | 1 |
| Bramanti, P | 1 |
| Solaro, C | 1 |
| Messmer Uccelli, M | 1 |
| Uccelli, A | 1 |
| Leandri, M | 1 |
| Mancardi, GL | 1 |
2 other studies available for carbamazepine and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Baclofen; Benzodiazepines; Carbamazepine; Female; GABA | 2011 |
Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Res | 2000 |